[Double-blind trial using the new inhalant corticosteroid Auxison in broncial asthma].
D000328:Adult; D000336:Aerosols; D000368:Aged; D000628:Aminophylline / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology; D002245:Carbon Dioxide / Q000378:metabolism; D002986:Clinical Trials as Topic; D003907:Dexamethasone / Q000627:therapeutic use*; D004809:Ephedrine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007539:Isonicotinic Acids / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010101:Oxygen Consumption; D010919:Placebos; D012126:Respiratory Dead Space; D012138:Respiratory Therapy; D013566:Sympathomimetics / Q000627:therapeutic use; D014797:Vital Capacity
D000336:Aerosols; D007539:Isonicotinic Acids; D010919:Placebos; D013566:Sympathomimetics; D002245:Carbon Dioxide; D000628:Aminophylline; D003907:Dexamethasone; D004809:Ephedrine
Doppeltblindversuch mit dem neuen inhalierbaren Kortikosteroid Auxison bei Asthma bronchiale.